Business Wire

Andersen Consulting udvider sine AI-kapaciteter med tilføjelsen af NextGen Invent

Del

Andersen Consulting indgår en samarbejdsaftale med NextGen Invent, en AI- og tech-tjenestevirksomhed med fokus på at levere innovative, datacentrerede løsninger, der styrker organisationers digitale transformationsplatform ved at integrere avanceret datavidenskab, AI og intelligente automatiseringsfunktioner.

NextGen Invent har hovedkontor i USA og har stor ekspertise inden for generativ AI, maskinlæring, datastrategi, avanceret analyse, digital produktudvikling, IoT og intelligent automatisering. Deres løsninger anvendes af nogle af de mest kendte brands inden for sundhedssektoren, finansielle tjenester, biovidenskab og fremstillingsindustrien. Med stor vægt på innovation hjælper NextGen Invent organisationer på tværs af disse brancher med at fremskynde digital modenhed, optimere driften og afdække nye muligheder for vækst. Virksomheden er kendt for sin teknologiske tankeledelse og evne til at skabe forretningsresultater gennem intelligente indsigter.

"Vores mission hos NextGen Invent er at hjælpe kunder med at forme fremtiden ved hjælp af intelligente teknologier. Samarbejdet med Andersen Consulting giver os mulighed for at øge vores indflydelse og udbrede vores styrker inden for datavidenskab og digital produktinnovation til en bredere kundebase," siger Deepak Mittal, grundlægger og CEO af NextGen Invent. "Sammen vil vi gøre det muligt for organisationer at træffe mere intelligente beslutninger og opnå hurtigere forretningsresultater."

"NextGen Invent passer perfekt til vores organisation, da vi løbende udvider vores AI-baserede og datadrevne kapaciteter," siger Mark L. Vorsatz, global bestyrelsesformand og administrerende direktør for Andersen. "Deres iværksætterånd, stærke kompetencer inden for AI og analyse samt fokus på målbare resultater er i tråd med vores mål om at levere transformative løsninger til kunder over hele verden. Dette samarbejde understreger vores forpligtelse til at hjælpe kunderne med at bevare konkurrencefordelen i deres respektive brancher ved at udnytte mulighederne i nye teknologier."

Andersen Consulting er en global konsulentvirksomhed, der tilbyder en komplet portefølje af tjenester inden for virksomhedsstrategi, forretningsudvikling, teknologi- og AI-transformation samt løsninger inden for humankapital. Andersen Consulting er integreret med den multidimensionelle servicemodel hos Andersen Global, der leverer brancheførende rådgivning inden for skat, jura, værdiansættelse, global mobilitet og forretningsrådgivning via en global platform med over 20.000 professionelle medarbejdere og tilstedeværelse på mere end 500 lokationer gennem sine medlemsfirmaer og samarbejdspartnere. Andersen Consulting Holdings LP er et kommanditselskab og tilbyder konsulenttjenester gennem sine medlemsfirmaer og samarbejdspartnere verden over.

Originalsprogsudgaven af denne bekendtgørelse er den officielle, autoriserede version. Oversættelserne er kun tænkt som en hjælp og bør sammenholdes med kildesprogsteksten, der som den eneste er juridisk bindende.

Se kildeudgaven på businesswire.com: https://www.businesswire.com/news/home/20250730018649/da/

Følg pressemeddelelser fra Business Wire

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra Business Wire

LevelBlue Completes Acquisition of Aon’s Cybersecurity and IP Litigation Consulting Groups1.8.2025 14:00:00 CEST | Press release

Strategic deal enhances LevelBlue's cybersecurity offerings, solidifying its position as the world’s largest leading independent, pure-play MSSP LevelBlue, a global leader in cloud-based, AI-driven managed security services, today announced the completion of its acquisition of Aon’s (NYSE: AON) Cybersecurity and Intellectual Property (IP) Litigation consulting groups, including the renowned cybersecurity firm, Stroz Friedberg, and Elysium Digital. With this completion the consulting group will operate as Stroz Friedberg, a LevelBlue company. This strategic acquisition adds elite cyber and high-tech IP litigation consulting expertise to the LevelBlue portfolio, which includes a globally recognized platform of approximately 300 technology professionals with deep relationships across Fortune 500 companies, 80 percent of the Am Law 100, and most of the UK’s top 20 law firms. As a result, LevelBlue will significantly fortify its incident response and advisory capabilities, while expanding i

SBC Medical to Announce Q2 2025 Financial Results and Hold Conference Call on August 13, 20251.8.2025 14:00:00 CEST | Press release

SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global franchise and provider of services for aesthetic clinics, today announced that it will report its Q2 2025 financial results on Wednesday, August 13, 2025, before the U.S. market opens. The Company will hold a conference call on Wednesday, August 13, 2025 at 8:30 am Eastern Time (or Wednesday, August 13, 2025 at 9:30 pm Japan Time) to discuss the financial results and take questions live. Please register in advance of the conference using the link provided below. https://edge.media-server.com/mmc/p/ukc9sp9j It will automatically direct you to the registration page of “SBC Q2 2025 Financial Results Presentation.” Please follow the steps to enter your registration details, then click “Submit.” Upon registration, you will be able to access the dedicated Conference Call viewing site. In addition to viewing the conference call, this site provides access to information about the speakers as well a

San’an and Inari to Acquire 100% of Lumileds Holding B.V.’s Shares1.8.2025 11:05:00 CEST | Press release

San’an Optoelectronics and Inari Amertron Berhad today announced they have entered into a definitive agreement to acquire Lumileds Holding B.V. and its European and Asian subsidiaries (“Lumileds International”). “This transaction is the next step of our ongoing transformation. As the LED industry evolves and continues to mature, I am confident that Lumileds International will continue to be successful and accelerate its growth under the new ownership,” said Steve Barlow, CEO of Lumileds International. The transaction is expected to close by the first quarter of 2026, subject to customary closing conditions. About Lumileds International Lumileds International is a global leader in LED technology, innovation, and solutions for the automotive, display, illumination, mobile, and other markets where light sources are essential. Our approximately 3,300 employees operate in over 15 countries to partner with our customers to deliver solutions for lighting, safety, and well-being. About San’an

Rimini Street Announces Fiscal Second Quarter 2025 Financial and Operating Results31.7.2025 22:01:00 CEST | Press release

Second Quarter Financial Highlights Include: Gross margin of 60.4% compared to 59.1% in the prior year Adjusted Calculated Billings of $107.9 million compared to $103.8 million in the prior year Adjusted EBITDA of $13.0 million compared to $8.8 million in the prior year Revenue Retention Rate of 90% compared to 88% in the prior year Rimini Street, Inc., (the “Company”) (Nasdaq: RMNI), a global provider of end-to-end enterprise software support and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced results for the fiscal second quarter ended June 30, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250731791846/en/ Rimini Street Announces Fiscal Second Quarter 2025 Financial and Operating Results Select Second Quarter 2025 Financial Results Revenue was $104.1 million for the 2025 second quarter, an increase of 1.0% compared to $103.1 million for the same

Altasciences and VoxCell BioInnovation Announce Strategic Collaboration to Advance Preclinical Drug Development31.7.2025 20:56:00 CEST | Press release

Altasciences, a fully integrated drug development solution company, and VoxCell BioInnovation (“VoxCell”), a leader in 3D bioprinting and human-like tissue modeling, are pleased to announce a strategic collaboration aimed at enhancing preclinical research and accelerating the path from discovery to clinical trials. This partnership combines Altasciences’ comprehensive early-phase drug development capabilities with VoxCell’s cutting-edge 3D tissue technology to offer a more predictive and human-relevant preclinical testing environment. By integrating VoxCell’s high-resolution 3D bioprinted tissue platforms into Altasciences’ discovery and preclinical services, both companies aim to reduce R&D timelines and increase the success rate of investigational therapies. “We’re proud to partner with VoxCell BioInnovation to bring next-generation tissue modeling into the early stages of drug development,” said Steve Mason, Co-Chief Operating Officer at Altasciences. “This collaboration aligns with

I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.

Besøg vores nyhedsrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye